Fibroblasts – from chromatin biology to therapy in autoimmunity and cancer

In den öffentlich zugänglichen Bereichen des USZ gilt eine Maskenpflicht.

An interdisciplinary panel of leaders in the fields of computational biology, single cell omics and fibroblast pathobiology in arthritis, fibrosis, and cancer will discuss the latest research into how discoveries about fibroblasts driven by single-cell omics and artificial intelligence are advancing pathobiology, patient stratification and therapies across arthritis, fibrosis and cancer.






4.00 pm - 6.40 pm CEST


4.00 pmWelcome
Oliver Distler, Zurich, Switzerland
4.10 pmHow advances in computational biology and single-cell omics can progress the biomedical research?
Mark Robinson, Zurich, Switzerland
4.30 pmSystemic fibrosis, fibroblasts: Machine learning – skin histology and gene expression for patient stratification
Dana Orange, Rockefeller University, NY, USA
4.50 pmPanel Discussion
Moderated by Mojca Frank Bertoncelj, Zurich, Switzerland
5.05 pmBreak
5.10 pmStromal cell activation in mouse and human arthritis – similarities and differences
Marietta Armaka, Alexander Fleming BSRC, Greece
5.30 pmMyofibroblasts – matrix mechanobiology, mechanotransduction and fibrosis
Boris Hinz, University of Toronto, Canada
5.50 pmCancer and fibrosis – investigative chromatin biology and beyond
Howard Y Chang, Stanford University, CA, USA
6.10 pmPanel Discussion
Moderated by Mojca Frank Bertoncelj, Zurich, Switzerland
6.30 pmSummary and conclusion
Caroline Ospelt, Zurich, Switzerland


Start Zoom Meeting

Meeting-ID: 634 0995 7912
Code: 541078


Kinga Kostyàl

Tel. +41 43 254 21 38

Verantwortlicher Fachbereich

This site is registered on as a development site. Switch to a production site key to remove this banner.